Cell-based interventions for therapeutic angiogenesis: Review of potential cell sources

Vascular

Volumn 20, Issue 6, 2012, Pages 360-368

  Brenes, Robert A ^a,b   Bear, Mackenzie ^a   Jadlowiec, Caroline ^a,c   Goodwin, Matthew ^a   Hashim, Peter ^a   Protack, Clinton D ^a   Ziegler, Kenneth R ^a   Li, Xin ^a   Model, Lynn S ^a   Lv, Wei ^a   Collins, Michael J ^a   Dardik, Alan ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST MARY S HOSPITAL   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Bone marrow; Endothelial progenitor cell; Mesenchymal progenitor cell; Monocyte; Stem cell; Therapeutic angiogenesis

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN;

ANGIOGENESIS; AUTOTRANSPLANTATION; BONE MARROW CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL LINEAGE; CELL POPULATION; CELL THERAPY; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISCHEMIA; MESENCHYMAL STEM CELL; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT;

ANIMALS; CELL DIFFERENTIATION; CHRONIC DISEASE; EXTREMITIES; HUMANS; ISCHEMIA; LIMB SALVAGE; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME;

EID: 84878368434     PISSN: 17085381     EISSN: 1708539X     Source Type: Journal    
DOI: 10.1258/vasc.2011.201205     Document Type: Review

References (77)

1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl. S):S5-67
2. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation 1999;99:111-20
3. Rajagopalan S, Mohler ER III, Lederman RJ, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003;108:1933-8
4. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-35
5. Miyamoto K, Nishigami K, Nagaya N, et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006;114:2679-84
6. Bartsch T, Brehm M, Zeus T, et al. Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease. J Cardiovasc Nurs 2006;21:430-2
7. Esato K, Hamano K, Li TS, et al. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 2002;11:747-52
8. Higashi Y, Kimura M, Hara K, et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004;109:1215-8
9. Miyamoto M, Yasutake M, Takano H, et al. Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transplant 2004;13:429-37
10. Saigawa T, Kato K, Ozawa T, et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004;68:1189-93
11. Durdu S, Akar AR, Arat M, et al. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. J Vasc Surg 2006;44:732-9
12. Kajiguchi M, Kondo T, Izawa H, et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 2007;71:196-201
13. Till JE, Mc CE. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961;14:213-22
14. Lorenz E, Uphoff D, Reid TR, et al. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951;12:197-201
15. Wu AM, Till JE, Siminovitch L, et al. A cytological study of the capacity for differentiation of normal hemopoietic colony-forming cells. J Cell Physiol 1967;69:177-84
16. Dick JE, Magli MC, Huszar D, et al. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell 1985;42:71-9
17. Keller G, Paige C, Gilboa E, et al. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature 1985;318:149-54
18. Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986; 45:917-27
19. Smith LG, Weissman IL, Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci USA 1991;88:2788-92
20. Osawa M, Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/ negative hematopoietic stem cell. Science 1996;273:242-5
21. Kiel MJ, Yilmaz OH, Iwashita T, et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005;121:1109-21
22. Dykstra B, Kent D, Bowie M, et al. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 2007;1:218-29
23. Mansson RZS, Bryder D, Sigvardsson M. The road to commitment: lineage restriction events in hematopoiesis. In: Wickrema A, Kee B, eds. Molecular Basis of Hematopoiesis. New York: Springer, 2009:23-46
24. Tavassoli M. Embryonic and fetal hemopoiesis: an overview. Blood Cells 1991;17:269-81; discussion 282-6
25. Zanjani ED, Ascensao JL, Tavassoli M. Liver-derived fetal hematopoietic stem cells selectively and preferentially home to the fetal bone marrow. Blood 1993;81:399-404
26. McGrath KE, Palis J. Hematopoiesis in the yolk sac: more than meets the eye. Exp Hematol 2005;33:1021-8
27. Pietila I, Vainio S. The embryonic aorta-gonad-mesonephros region as a generator of haematopoietic stem cells. APMIS 2005;113:804-12
28. Morrison SJ, Uchida N, Weissman IL. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol 1995; 11:35-71
29. Ogawa M. Effects of hemopoietic growth factors on stem cells in vitro. Hematol Oncol Clin North Am 1989;3:453-64
30. Ogawa M. Hemopoietic stem cells: stochastic differentiation and humoral control of proliferation. Environ Health Perspect 1989;80:199-207
31. Graf T. Differentiation plasticity of hematopoietic cells. Blood 2002;99:3089-101
32. Asahara T, Murohara T, Sullivan A, et al. Isolation of putativeprogenitor endothelial cells for angiogenesis. Science 1997; 275:964-7
33. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999;103:1231-6
34. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-60
35. de Muinck ED, Simons M. Re-evaluating therapeutic neovascularization. J Mol Cell Cardiol 2004;36:25-32
36. Helisch A, Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation 2003;10:83-97
37. Capiod JC, Tournois C, Vitry F, et al. Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product. Vox Sang 2009;96:256-65
38. Hernandez P, Cortina L, Artaza H, et al. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation. Atherosclerosis 2007;194:e52-6
39. Magri D, Vasilas P, Muto A, et al. Elevated monocytes in patients with critical limb ischemia diminish after bypass surgery. J Surg Res 2011;167:140-50
40. Huang P, Li S, Han M, et al. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005;28:2155-60
41. Kawamura A, Horie T, Tsuda I, et al. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs 2006;9:226-33
42. Iba O, Matsubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002;106:2019-25
43. Li S, Zhou B, Han ZC. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34- mononuclear cells. Thromb Haemost 2006;95:301-11
44. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-52
45. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-6
46. Honold J, Lehmann R, Heeschen C, et al. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease. Arterioscler Thromb Vasc Biol 2006;26:2238-43
47. Zhou B, Liu PX, Lan HF, et al. Enhancement of neovascularization with mobilized blood cells transplantation: supply of angioblasts and angiogenic cytokines. J Cell Biochem 2007;102:183-95
48. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968;128:415-35
49. Geissmann F, Manz MG, Jung S, et al. Development of monocytes, macrophages, and dendritic cells. Science 2010;327: 656-61
50. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009;27:669-92
51. Auffray C, Fogg D, Garfa M, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007;317:666-70
52. Nahrendorf M, Swirski FK, Aikawa E, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007;204:3037-47
53. Arnold L, Henry A, Poron F, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into anti-inflammatory macrophages to support myogenesis. J Exp Med 2007;204:1057-69
54. Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000;95:3106-12
55. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004;8:498-508
56. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8
57. Napoli C, Hayashi T, Cacciatore F, et al. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. Atherosclerosis 2011;215:9-22
58. Shantsila E, Watson T, Tse HF, et al. New insights on endothelial progenitor cell subpopulations and their angiogenic properties. J Am Coll Cardiol 2008;51:669-71
59. Sieveking DP, Buckle A, Celermajer DS, et al. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008;51:660-8
60. Timmermans F, Van Hauwermeiren F, De Smedt M, et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007;27:1572-9
61. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-72
62. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95
63. Rehman J, Li J, Orschell CM, et al. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107: 1164-9
64. Banfi A, von Degenfeld G, Blau HM. Critical role of microenvironmental factors in angiogenesis. Curr Atheroscler Rep 2005;7:227-34
65. Fazel S, Cimini M, Chen L, et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116:1865-77
66. Tse HF, Siu CW, Zhu SG, et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 2007;9:747-53
67. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-8
68. Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634-7
69. Leone AM, Rutella S, Bonanno G, et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005;26:1196-204
70. Xu Q, Zhang Z, Davison F, et al. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 2003;93: e76-86
71. Lasala GP, Silva JA, Gardner PA, et al. Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis. Angiology 2010;61:551-6
72. Chamberlain G, Fox J, Ashton B, et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25:2739-49
73. La Rocca G, Anzalone R, Corrao S, et al. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 2009;131: 267-82
74. Gojo S, Gojo N, Takeda Y, et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 2003;288:51-9
75. Rookmaaker MB, Verhaar MC, Loomans CJ, et al. CD34+ cells home, proliferate, and participate in capillary formation, and in combination with CD34- cells enhance tube formation in a 3-dimensional matrix. Arterioscler Thromb Vasc Biol 2005;25:1843-50
76. Harraz M, Jiao C, Hanlon HD, et al. CD34- blood-derived human endothelial cell progenitors. Stem Cells 2001;19:304-12
77. Urbich C, Heeschen C, Aicher A, et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003;108:2511-6